Innate Conformational Dynamics Drive Binding Specificity in Anti-Apoptotic Proteins Mcl-1 and Bcl-2

被引:2
|
作者
Wolf, Esther [1 ]
Lento, Cristina [1 ]
Pu, Jinyue [2 ]
Dickinson, Bryan C. [2 ]
Wilson, Derek J. [1 ]
机构
[1] York Univ, Dept Chem, Toronto, ON M3J 1P3, Canada
[2] Univ Chicago, Dept Chem, Chicago, IL 60637 USA
基金
加拿大自然科学与工程研究理事会; 美国国家卫生研究院;
关键词
MASS-SPECTROMETRY; BH3; DOMAINS; EXCHANGE; FAMILY; MITOCHONDRIA; INHIBITION; ACTIVATION; PEPTIDES; AFFINITY; LIGANDS;
D O I
10.1021/acs.biochem.2c00709
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The structurally conserved B-cell lymphoma 2 (Bcl-2)family ofprotein function to promote or inhibit apoptosis through an exceedinglycomplex web of specific, intrafamilial protein-protein interactions.The critical role of these proteins in lymphomas and other cancershas motivated a widespread interest in understanding the molecularmechanisms that drive specificity in Bcl-2 family interactions. However,the high degree of structural similarity among Bcl-2 homologues hasmade it difficult to rationalize the highly specific (and often divergent)binding behavior exhibited by these proteins using conventional structuralarguments. In this work, we use time-resolved hydrogen deuterium exchangemass spectrometry to explore shifts in conformational dynamics associatedwith binding partner engagement in the Bcl-2 family proteins Bcl-2and Mcl-1. Using this approach combined with homology modeling, wereveal that Mcl-1 binding is driven by a large-scale shift in conformationaldynamics, while Bcl-2 complexation occurs primarily through a classicalcharge compensation mechanism. This work has implications for understandingthe evolution of internally regulated biological systems composedof structurally similar proteins and for the development of drugstargeting Bcl-2 family proteins for promotion of apoptosis in cancer.
引用
收藏
页码:1619 / 1630
页数:12
相关论文
共 50 条
  • [21] IMMUNOHISTOCHEMISTRY FOR ANTI-APOPTOTIC PROTEINS MCL-1 AND BCL-X IN CANINE NORMAL TISSUES AND LYMPHOMA SAMPLES
    Zeller, S.
    Keller, S.
    Schade, B.
    Keller, B.
    Brugnera, E.
    Guscetti, F.
    JOURNAL OF COMPARATIVE PATHOLOGY, 2009, 141 (04) : 275 - 275
  • [22] Impact of elevated anti-apoptotic MCL-1 and BCL-2 on the development and treatment of MLL-AF9 AML in mice
    Anstee, Natasha S.
    Bilardi, Rebecca A.
    Ng, Ashley P.
    Xu, Zhen
    Robati, Mikara
    Vandenberg, Cassandra J.
    Cory, Suzanne
    CELL DEATH AND DIFFERENTIATION, 2019, 26 (07): : 1316 - 1331
  • [23] ER plus Breast Cancer Strongly Depends on MCL-1 and BCL-xL Anti-Apoptotic Proteins
    Alcon, Clara
    Tejeda Zanudo, Jorge Gomez
    Albert, Reka
    Wagle, Nikhil
    Scaltriti, Maurizio
    Letai, Anthony
    Samitier, Josep
    Montero, Joan
    CELLS, 2021, 10 (07)
  • [24] Mcl-1, an anti-apoptotic Bcl-2 family member, essentially overlaps with insulin-producing cells in neonatal nesidioblastosis
    Makoto Sano
    Emiko Hayashi
    Hitohiko Murakami
    Hiroshi Kishimoto
    Ryuji Fukuzawa
    Norimichi Nemoto
    Virchows Archiv, 2008, 452 : 469 - 470
  • [25] Anti-apoptotic Bcl-2 family member Mcl-1 regulates cell viability and bone-resorbing activity of osteoclasts
    Masuda, Hironari
    Hirose, Jun
    Omata, Yasunori
    Tokuyama, Naoto
    Yasui, Tetsuro
    Kadono, Yuho
    Miyazaki, Tsuyoshi
    Tanaka, Sakae
    BONE, 2014, 58 : 1 - 10
  • [26] Impact of elevated anti-apoptotic MCL-1 and BCL-2 on the development and treatment of MLL-AF9 AML in mice
    Natasha S. Anstee
    Rebecca A. Bilardi
    Ashley P. Ng
    Zhen Xu
    Mikara Robati
    Cassandra J. Vandenberg
    Suzanne Cory
    Cell Death & Differentiation, 2019, 26 : 1316 - 1331
  • [27] Mcl-1, an anti-apoptotic Bcl-2 family member, essentially overlaps with insulin-producing cells in neonatal nesidioblastosis
    Sano, Makoto
    Hayashi, Emiko
    Murakami, Hitohiko
    Kishimoto, Hiroshi
    Fukuzawa, Ryuji
    Nemoto, Norimichi
    VIRCHOWS ARCHIV, 2008, 452 (04) : 469 - 470
  • [28] Mcl-1 is an important anti-apoptotic factor for hepatocytes
    Vick, B.
    Weber, A.
    Urbanik, T.
    Gallel, P. R.
    Schulze-Bergkamen, H.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S168 - S168
  • [29] Inhibitors of the anti-apoptotic Bcl-2 proteins: a patent review
    Bajwa, Naval
    Liao, Chenzhong
    Nikolovska-Coleska, Zaneta
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2012, 22 (01) : 37 - 55
  • [30] Development of dimeric modulators for anti-apoptotic Bcl-2 proteins
    Wang, Liangyou
    Kong, Fansen
    Kokoski, Candis L.
    Andrews, David W.
    Xing, Chengguo
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (01) : 236 - 240